BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 20017581)

  • 1. Computational toxicology approaches at the US Food and Drug Administration.
    Yang C; Valerio LG; Arvidson KB
    Altern Lab Anim; 2009 Nov; 37(5):523-31. PubMed ID: 20017581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory use of computational toxicology tools and databases at the United States Food and Drug Administration's Office of Food Additive Safety.
    Arvidson KB; Chanderbhan R; Muldoon-Jacobs K; Mayer J; Ogungbesan A
    Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):793-6. PubMed ID: 20491519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing computational toxicology models with phytochemicals.
    Valerio LG; Arvidson KB; Busta E; Minnier BL; Kruhlak NL; Benz RD
    Mol Nutr Food Res; 2010 Feb; 54(2):186-94. PubMed ID: 20024931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public databases supporting computational toxicology.
    Judson R
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):218-31. PubMed ID: 20574898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico toxicology models and databases as FDA Critical Path Initiative toolkits.
    Valerio LG
    Hum Genomics; 2011 Mar; 5(3):200-7. PubMed ID: 21504870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and validation of an in silico toxicology model to predict the mutagenic potential of drug impurities.
    Valerio LG; Cross KP
    Toxicol Appl Pharmacol; 2012 May; 260(3):209-21. PubMed ID: 22426359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico toxicology for the pharmaceutical sciences.
    Valerio LG
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR Models at the US FDA/NCTR.
    Hong H; Chen M; Ng HW; Tong W
    Methods Mol Biol; 2016; 1425():431-59. PubMed ID: 27311476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of toxicological information in drug design.
    Matthews EJ; Benz RD; Contrera JF
    J Mol Graph Model; 2000 Dec; 18(6):605-15. PubMed ID: 11155316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicological and clinical computational analysis and the US FDA/CDER.
    Benz RD
    Expert Opin Drug Metab Toxicol; 2007 Feb; 3(1):109-24. PubMed ID: 17269898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
    Kavlock R; Dix D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational toxicology: an overview of the sources of data and of modelling methods.
    Nigsch F; Macaluso NJ; Mitchell JB; Zmuidinavicius D
    Expert Opin Drug Metab Toxicol; 2009 Jan; 5(1):1-14. PubMed ID: 19236225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in QSAR toxicity screening of pharmaceutical impurities and other FDA regulated products.
    Kruhlak NL; Contrera JF; Benz RD; Matthews EJ
    Adv Drug Deliv Rev; 2007 Jan; 59(1):43-55. PubMed ID: 17229485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans. Part A: use of FDA post-market reports to create a database of hepatobiliary and urinary tract toxicities.
    Ursem CJ; Kruhlak NL; Contrera JF; MacLaughlin PM; Benz RD; Matthews EJ
    Regul Toxicol Pharmacol; 2009 Jun; 54(1):1-22. PubMed ID: 19422096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA toxicity databases and real-time data entry.
    Arvidson KB
    Toxicol Appl Pharmacol; 2008 Nov; 233(1):17-9. PubMed ID: 18656494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational science in drug metabolism and toxicology.
    Valerio LG
    Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):781-4. PubMed ID: 20465524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive computational toxicology to support drug safety assessment.
    Valerio LG
    Methods Mol Biol; 2013; 930():341-54. PubMed ID: 23086849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggregating data for computational toxicology applications: The U.S. Environmental Protection Agency (EPA) Aggregated Computational Toxicology Resource (ACToR) System.
    Judson RS; Martin MT; Egeghy P; Gangwal S; Reif DM; Kothiya P; Wolf M; Cathey T; Transue T; Smith D; Vail J; Frame A; Mosher S; Hubal EAC; Richard AM
    Int J Mol Sci; 2012; 13(2):1805-1831. PubMed ID: 22408426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward a unifying strategy for the structure-based prediction of toxicological endpoints.
    CarriĆ³ P; Sanz F; Pastor M
    Arch Toxicol; 2016 Oct; 90(10):2445-60. PubMed ID: 26553148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.